Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis

PURPOSE: Conventional osteosarcoma is an orphan disease. Current treatment approaches include combining a three drug chemotherapy schedule and surgery. The 3- and 5-year event-free survival (EFS) in localized disease is roughly 65 and 60%, respectively. The registration study of mifamurtide reported...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Bone Oncol
Hauptverfasser: Múdry, Peter, Kýr, Michal, Rohleder, Ondřej, Mahdal, Michal, Staniczková Zambo, Iva, Ježová, Marta, Tomáš, Tomáš, Štěrba, Jaroslav
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8080518/
https://ncbi.nlm.nih.gov/pubmed/33948428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2021.100362
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge